Johnson Matthey Fine Chemicals provides an extensive range of APIs in addition to our broad portfolio of controlled substances. We have specific expertise in high potency cytotoxics including platinum-based oncology actives, high purity cannabidiols and prostaglandins. Moreover our products cover a wide range of therapeutic classes such as anti-cancer, anti-rheumatic, addiction, psychiatric disorders and ophthalmic indications.
We are continually looking to expand and increase our API portfolio through collaborative working – a core principle at Johnson Matthey Fine Chemicals. Our APIs & Life Cycle Management partnership offering combines flexible and innovative business models with collaborative process development to strengthen your products, while reducing your risk. Whether it is through API development and supply, technical support through drug development processes or financial investment to assist our partners in bringing their drug products to market, our goal is to deliver beyond the needs of our partners.